Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice

I. Baiardini, F. Braido, G. Molinengo, M. Caminati, M. Costantino, A. Cristaudo, M. Crivellaro, S.M. Ferrucci, R. Gallo, V. Giorgis, A. Legori, B. Loera, I. Martignago, A.V. Marzano, A. Morrone, R. Parente, A. Parodi, A. Parolo, S. Peveri, P. PigattoA. Radice, E. Ridolo, G. Rolla, C. Roncallo, O. Rossi, E. Savi, G. Senna, M. Triggiani, G.W. Canonica

Research output: Contribution to journalArticle

Abstract

There is a need for validated tools to assess health-related quality of life (HRQoL) in routine clinical practice. OBJECTIVE: The aim of this study was to validate the Chronic Urticaria Patient Perspective (CUPP) for assessment of patients with chronic urticaria (CU) in clinical practice. METHODS: A provisional CUPP was developed from candidate items identified by following an iterative process in a retrospective analysis of 249 Chronic Urticaria Quality of Life Questionnaire questionnaires. The psychometric properties of the CUPP were then tested on a sample of patients enrolled in 13 Italian centers. RESULTS: The study population in the validation phase comprised 152 patients. The 10-item version of the CUPP showed satisfactory internal consistency (Cronbach's alpha values of 0.76 at visit 1 and 0.90 at visit 2), good criteria, and discriminative and convergent validity. Reliability was assessed in 34 patients with no changes in health (Global Rating Scale = 0 at visit 2) and was satisfactory (CCC [concordance correlation coefficient] = 0.9). Changes in CUPP scores were significantly associated with changes in Urticaria Activity Score (UAS)-Hive count (r = 0.36, P < .001), UAS-Itch severity (r = 0.48, P < .001), and UAS-Total score (r = 0.342, P < .001), all of which indicated good responsiveness. The minimal important difference was 1.5. CONCLUSIONS: CUPP is a simple 10-question tool with good psychometric properties that provides a valid, reliable, and standardized measurement of HRQoL in patients with CU. KEYWORDS: Assessment; Chronic urticaria; Clinical practice; Quality of life; Routine
Original languageItalian
Pages (from-to)208-218
Number of pages11
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume6
Issue number1
Early online dateAug 9 2017
DOIs
Publication statusPublished - 2018

Cite this

Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice. / Baiardini, I.; Braido, F.; Molinengo, G.; Caminati, M.; Costantino, M.; Cristaudo, A.; Crivellaro, M.; Ferrucci, S.M.; Gallo, R.; Giorgis, V.; Legori, A.; Loera, B.; Martignago, I.; Marzano, A.V.; Morrone, A.; Parente, R.; Parodi, A.; Parolo, A.; Peveri, S.; Pigatto, P.; Radice, A.; Ridolo, E.; Rolla, G.; Roncallo, C.; Rossi, O.; Savi, E.; Senna, G.; Triggiani, M.; Canonica, G.W.

In: Journal of Allergy and Clinical Immunology: In Practice, Vol. 6, No. 1, 2018, p. 208-218.

Research output: Contribution to journalArticle

Baiardini, I, Braido, F, Molinengo, G, Caminati, M, Costantino, M, Cristaudo, A, Crivellaro, M, Ferrucci, SM, Gallo, R, Giorgis, V, Legori, A, Loera, B, Martignago, I, Marzano, AV, Morrone, A, Parente, R, Parodi, A, Parolo, A, Peveri, S, Pigatto, P, Radice, A, Ridolo, E, Rolla, G, Roncallo, C, Rossi, O, Savi, E, Senna, G, Triggiani, M & Canonica, GW 2018, 'Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice', Journal of Allergy and Clinical Immunology: In Practice, vol. 6, no. 1, pp. 208-218. https://doi.org/10.1016/j.jaip.2017.06.023
Baiardini, I. ; Braido, F. ; Molinengo, G. ; Caminati, M. ; Costantino, M. ; Cristaudo, A. ; Crivellaro, M. ; Ferrucci, S.M. ; Gallo, R. ; Giorgis, V. ; Legori, A. ; Loera, B. ; Martignago, I. ; Marzano, A.V. ; Morrone, A. ; Parente, R. ; Parodi, A. ; Parolo, A. ; Peveri, S. ; Pigatto, P. ; Radice, A. ; Ridolo, E. ; Rolla, G. ; Roncallo, C. ; Rossi, O. ; Savi, E. ; Senna, G. ; Triggiani, M. ; Canonica, G.W. / Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice. In: Journal of Allergy and Clinical Immunology: In Practice. 2018 ; Vol. 6, No. 1. pp. 208-218.
@article{66618d402ada4e90af1c28d5dd3a5259,
title = "Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice",
abstract = "There is a need for validated tools to assess health-related quality of life (HRQoL) in routine clinical practice. OBJECTIVE: The aim of this study was to validate the Chronic Urticaria Patient Perspective (CUPP) for assessment of patients with chronic urticaria (CU) in clinical practice. METHODS: A provisional CUPP was developed from candidate items identified by following an iterative process in a retrospective analysis of 249 Chronic Urticaria Quality of Life Questionnaire questionnaires. The psychometric properties of the CUPP were then tested on a sample of patients enrolled in 13 Italian centers. RESULTS: The study population in the validation phase comprised 152 patients. The 10-item version of the CUPP showed satisfactory internal consistency (Cronbach's alpha values of 0.76 at visit 1 and 0.90 at visit 2), good criteria, and discriminative and convergent validity. Reliability was assessed in 34 patients with no changes in health (Global Rating Scale = 0 at visit 2) and was satisfactory (CCC [concordance correlation coefficient] = 0.9). Changes in CUPP scores were significantly associated with changes in Urticaria Activity Score (UAS)-Hive count (r = 0.36, P < .001), UAS-Itch severity (r = 0.48, P < .001), and UAS-Total score (r = 0.342, P < .001), all of which indicated good responsiveness. The minimal important difference was 1.5. CONCLUSIONS: CUPP is a simple 10-question tool with good psychometric properties that provides a valid, reliable, and standardized measurement of HRQoL in patients with CU. KEYWORDS: Assessment; Chronic urticaria; Clinical practice; Quality of life; Routine",
author = "I. Baiardini and F. Braido and G. Molinengo and M. Caminati and M. Costantino and A. Cristaudo and M. Crivellaro and S.M. Ferrucci and R. Gallo and V. Giorgis and A. Legori and B. Loera and I. Martignago and A.V. Marzano and A. Morrone and R. Parente and A. Parodi and A. Parolo and S. Peveri and P. Pigatto and A. Radice and E. Ridolo and G. Rolla and C. Roncallo and O. Rossi and E. Savi and G. Senna and M. Triggiani and G.W. Canonica",
note = "Export Date: 5 March 2018",
year = "2018",
doi = "10.1016/j.jaip.2017.06.023",
language = "Italian",
volume = "6",
pages = "208--218",
journal = "Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "American Academy of Allergy, Asthma and Immunology",
number = "1",

}

TY - JOUR

T1 - Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice

AU - Baiardini, I.

AU - Braido, F.

AU - Molinengo, G.

AU - Caminati, M.

AU - Costantino, M.

AU - Cristaudo, A.

AU - Crivellaro, M.

AU - Ferrucci, S.M.

AU - Gallo, R.

AU - Giorgis, V.

AU - Legori, A.

AU - Loera, B.

AU - Martignago, I.

AU - Marzano, A.V.

AU - Morrone, A.

AU - Parente, R.

AU - Parodi, A.

AU - Parolo, A.

AU - Peveri, S.

AU - Pigatto, P.

AU - Radice, A.

AU - Ridolo, E.

AU - Rolla, G.

AU - Roncallo, C.

AU - Rossi, O.

AU - Savi, E.

AU - Senna, G.

AU - Triggiani, M.

AU - Canonica, G.W.

N1 - Export Date: 5 March 2018

PY - 2018

Y1 - 2018

N2 - There is a need for validated tools to assess health-related quality of life (HRQoL) in routine clinical practice. OBJECTIVE: The aim of this study was to validate the Chronic Urticaria Patient Perspective (CUPP) for assessment of patients with chronic urticaria (CU) in clinical practice. METHODS: A provisional CUPP was developed from candidate items identified by following an iterative process in a retrospective analysis of 249 Chronic Urticaria Quality of Life Questionnaire questionnaires. The psychometric properties of the CUPP were then tested on a sample of patients enrolled in 13 Italian centers. RESULTS: The study population in the validation phase comprised 152 patients. The 10-item version of the CUPP showed satisfactory internal consistency (Cronbach's alpha values of 0.76 at visit 1 and 0.90 at visit 2), good criteria, and discriminative and convergent validity. Reliability was assessed in 34 patients with no changes in health (Global Rating Scale = 0 at visit 2) and was satisfactory (CCC [concordance correlation coefficient] = 0.9). Changes in CUPP scores were significantly associated with changes in Urticaria Activity Score (UAS)-Hive count (r = 0.36, P < .001), UAS-Itch severity (r = 0.48, P < .001), and UAS-Total score (r = 0.342, P < .001), all of which indicated good responsiveness. The minimal important difference was 1.5. CONCLUSIONS: CUPP is a simple 10-question tool with good psychometric properties that provides a valid, reliable, and standardized measurement of HRQoL in patients with CU. KEYWORDS: Assessment; Chronic urticaria; Clinical practice; Quality of life; Routine

AB - There is a need for validated tools to assess health-related quality of life (HRQoL) in routine clinical practice. OBJECTIVE: The aim of this study was to validate the Chronic Urticaria Patient Perspective (CUPP) for assessment of patients with chronic urticaria (CU) in clinical practice. METHODS: A provisional CUPP was developed from candidate items identified by following an iterative process in a retrospective analysis of 249 Chronic Urticaria Quality of Life Questionnaire questionnaires. The psychometric properties of the CUPP were then tested on a sample of patients enrolled in 13 Italian centers. RESULTS: The study population in the validation phase comprised 152 patients. The 10-item version of the CUPP showed satisfactory internal consistency (Cronbach's alpha values of 0.76 at visit 1 and 0.90 at visit 2), good criteria, and discriminative and convergent validity. Reliability was assessed in 34 patients with no changes in health (Global Rating Scale = 0 at visit 2) and was satisfactory (CCC [concordance correlation coefficient] = 0.9). Changes in CUPP scores were significantly associated with changes in Urticaria Activity Score (UAS)-Hive count (r = 0.36, P < .001), UAS-Itch severity (r = 0.48, P < .001), and UAS-Total score (r = 0.342, P < .001), all of which indicated good responsiveness. The minimal important difference was 1.5. CONCLUSIONS: CUPP is a simple 10-question tool with good psychometric properties that provides a valid, reliable, and standardized measurement of HRQoL in patients with CU. KEYWORDS: Assessment; Chronic urticaria; Clinical practice; Quality of life; Routine

U2 - 10.1016/j.jaip.2017.06.023

DO - 10.1016/j.jaip.2017.06.023

M3 - Articolo

VL - 6

SP - 208

EP - 218

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

SN - 2213-2198

IS - 1

ER -